EPAM Systems reported 14% year-over-year organic revenue growth in Q3 2025, driven by accelerated AI-enabled engagements in financial services and technology sectors. The company generated a record $320 million in operating cash flow for the quarter, up 22% from Q3 2024, and raised its full-year revenue growth guidance by 100 basis points to a range of 12.5%–13.5%. Despite these operational improvements, EPAM’s shares have climbed roughly 30% since the results release, positioning the stock at a 25% premium to peer multiples. Investors should note that utilization rates remain near 78%, below historical levels, and operating margins compressed by 150 basis points sequentially due to higher subcontracting costs, creating potential downside if cost pressures persist.

Management underscored its AI-first strategic roadmap, highlighting that 40% of new client contracts signed in Q3 incorporate GenAI components via the EPAM AI/RUN™ platform. The launch of the DIALX Lab initiative has already piloted more than 20 enterprise use cases, including automated claims processing for a top-tier insurer and real-time personalized banking solutions. EPAM’s delivery network now spans 35 countries, with recent expansions in Eastern Europe and Southeast Asia expected to support a 10% headcount increase over the next 12 months. While this geographic diversification reduces geopolitical risk, investors should monitor margin dilution from regional wage inflation and integration costs of new delivery centers.

EPAM will host its 2026 Investor Day on March 12 in Boston, featuring presentations by CEO Balazs Fejes and CFO Jason Peterson. The event will review progress against three strategic priorities: scaling AI-native engineering, deepening vertical-specific solutions and enhancing client lifetime value. Presenters will showcase live demos of AI-driven platforms and share case studies from clients in manufacturing and life sciences. In-person attendance is invitation-only, with the webcast scheduled to begin at 8:30 am ET and conclude at 12:30 pm ET, followed by a leadership luncheon. Management has indicated that board approval is pending for a new share repurchase authorization, signaling confidence in cash-flow generation beyond the current $850 million balance sheet cash position.